The global automated breast ultrasound systems market is expected to advance by one year CAGR of 9.7% from 2023 to 2033. The market is rated with $1.7 billion in 2023 and is expected to be achieved $4.3 billion until the end of 2033.

The market study includes market research analysis and insights that show how consumers react to a product already on the market and reveals the reasons why a particular product fails. The comprehensive market report has the potential to reveal general market trends and conditions. This research makes it easy to assess the potential market for a newly launched product. Market Research Report is a resource that offers up-to-date technical and financial information about the sector for the expected period.

Download a sample copy of this report :- https://www.factmr.com/connectus/sample?flag=S&rep_id=585

ABUS gains a competitive advantage over HHUS

Breast cancer has emerged as the most commonly diagnosed cancer and has become the second leading cause of death in women, according to statistics published by the National Breast Cancer Foundation. With growing awareness of breast cancer, the number of screening methods has multiplied, increasing the demand for advanced diagnostic and follow-up technologies such as automated breast ultrasound systems in diagnostic centers and hospitals. Facilitating screening of denser breast tissue along with providing superior image quality has given the Automated Breast Ultrasound System (ABUS) a competitive advantage over the Portable Ultrasound System (HHUS).

With automated breast ultrasound systems approved by the FDA for screening in concert with mammography, radiologists are increasingly turning to this technology for women with denser breast tissue. Based on the high quality 3D images offered by ABUS, surgeons use the preoperative breast assessment system to accurately determine tumor size and location. However, high costs and…